Inventor

LEBLANC YVES

US63 patents

⚠️ This page may combine multiple inventors who share the name “LEBLANC YVES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LEBLANC YVES

MERCK FROSST CANADA INC

(Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors

Phenyl heterocycles as COX-2 inhibitors

N-benzyl indol-3-yl butanoic acid derivatives as cyclooxygenase inhibitors

N-benzylindol-3-yl propanoic acid derivatives as cyclooxygenase inhibitors

Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents

Phenyl heterocycles as cox-2 inhibitors

Phenyl heterocycles as COX-2 inhibitors

Phenyl heterocycles as cox-2 inhibitors

Aryldifluoromethylphosphonic acids with sulfur-containing substituents as PTP-1B inhibitors

Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases

Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists

Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)

Phosphonic acids derivatives as inhibitors of protein tyrosine phosphate 1B (PTP-1B)

(Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors

(Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors

Hydroxyalkylquinoline ether acids as leukotriene antagonists

Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)

Phosphonic acid biaryl derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)

Phosphonic and carboxylic acid derivatives as inhibitors of protein tyrosine phosphatase-1B (PTP-1B)

Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists

Protein tyrosine phosphatase 1B (PTP-1B) inhibitors containing two ortho-substituted aromatic phosphonates

Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases

Protein tyrosine phosphatase 1B (PTP-1B) inhibitors containing two ortho-substituted aromatic phosphonates

Ligands for phosphatase binding assay

Aryldifluoromethylphosphonic acids for treatment of diabetes

Heteroaryl and haloaryl quinoline derivatives of cyclopropaneacetic acid as leukotriene antagonists

DH TECHNOLOGIES DEV PTE LTD

Fluid transfer from digital microfluidic device

Method and system for introducing make-up flow in an electrospray ion source system

Methods for detection in differential mobility spectrometer using a peptide metal complex

Methods for selective detection of biologically relevant acids

Reducing interferences in isobaric tag-based quantification

Differential mobility spectrometer and methods thereof

Isomeric reagent tags for differential mobility spectrometry

Methods for analysis of isomeric lipids

MDS INC

Broad ion fragmentation coverage in mass spectrometry by varying the collision energy

Mass defect triggered information dependent acquisition

Broad ion fragmentation coverage in mass spectrometry by varying the collision energy

Method, system and computer software product for specific identification of reaction pairs associated by specific neutral differences

GENENTECH INC

Therapeutic compounds and uses thereof

Therapeutic compounds and uses thereof

Pyrazolo[1,5-A]pyrimidin-7(4H)-onehistone demethylase inhibitors

Therapeutic compounds and uses thereof

MERCK FROSST CANADA LTD

Pyridine analogs as C5a antagonists

Pyridopyrrolizine and pyridoindolizine derivatives

ALBRECHT BRIAN K

Bromodomain inhibitors and uses thereof

TRUCHON JEAN-FRANCOIS

Tricyclic compounds useful as inhibitors of kinases

CONSTELLATION PHARMACEUTICALS INC

Bromodomain inhibitors and uses thereof

MERK FROSST CANADA INC

(methylsulfonyl)phenyl-2-(5H)-furanones with oxygen link as COX-2 inhibitors

LEBLANC YVES

Azaindole derivatives as CRTH2 receptor antagonists

HASSELL KERRY M

Method and apparatus for conversion of multiple analyte cation types to a single analyte anion type via ion/ion charge inversion